CARGO Therapeutics, Inc. (CRGX)
| Market Cap | 213.51M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -216.19M |
| Shares Out | 46.52M |
| EPS (ttm) | -4.63 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,172,807 |
| Open | 4.600 |
| Previous Close | 4.600 |
| Day's Range | 4.570 - 4.600 |
| 52-Week Range | 3.000 - 25.450 |
| Beta | n/a |
| Analysts | Hold |
| Price Target | 5.33 (+16.25%) |
| Earnings Date | Aug 11, 2025 |
About CRGX
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, focused on designing, engineering, and developing potentially curative cell therapies for cancer patients in the United States. The company develops CRG-023, a tri-specific CAR T product candidate which is in phase 1 that targets tumor cells with three B-cell malignancies; and allogeneic platform, a universal vector solution designed to effectively limit immune-based rejection to enable durable response of CAR T-cell therapy. The company was formerly known as Syncopation Life Sci... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for CRGX stock is "Hold." The 12-month stock price target is $5.33, which is an increase of 16.25% from the latest price.
News
CARGO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CARGO Therapeutics, Inc. - CRGX
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ...
CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right
SAN CARLOS, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (“CARGO” or the “Company”) (NASDAQ: CRGX), a biotechnology company that has focused on developing CAR T-cell therapies, t...
CARGO Therapeutics Provides Corporate Update
- Development of CRG-023 and allogeneic platform suspended; further reduction in force (RIF) of approximately 90% to preserve cash and maximize shareholder value - - CARGO had cash, cash equivalents a...
The Schall Law Firm Invites Shareholders With Losses In CARGO Therapeutics, Inc. To Join A Securities Fraud Investigation
LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CARGO Therap...
CARGO Therapeutics, Inc. (CRGX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. ("CARGO" or "the Company")...
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Shareholders to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. ("CARGO" or "the Company")...
Bronstein, Gewirtz & Grossman, LLC Is Investigating CARGO Therapeutics, Inc. (CRGX) And Encourages Shareholders to Connect
NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. ("CARGO" or "the Company")...
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CARGO Therapeutics, Inc. (CRGX) And Encourages Shareholders to Reach Out
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. ("CARGO" or "the Company")...
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Stockholders to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. ("CARGO" or "the Company") ...
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CARGO Therapeutics, Inc. (CRGX) and Encourages Investors to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / February 7, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. ("CARGO" or "the Company") ...
CRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm
LOS ANGELES , Feb. 6, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CARGO Therapeutics, I...
CARGO Therapeutics, Inc. (CRGX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / February 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. ("CARGO" or "the Company") ...
Bronstein, Gewirtz & Grossman, LLC Is Investigating CARGO Therapeutics, Inc. (CRGX) And Encourages Investors to Connect
NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. ("CARGO" or "the Company") ...
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CARGO Therapeutics, Inc. (CRGX) and Encourages Stockholders to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. ("CARGO" or "the Company") ...
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Investors to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. ("CARGO" or "the Company") ...
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CARGO Therapeutics, Inc. (CRGX) And Encourages Investors to Reach Out
NEW YORK, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CARGO Therapeutics, Inc. ("CARGO" or "the Company") ...